Endocrinology, Vol 132, 1247-1251, Copyright © 1993 by Endocrine Society

ARTICLES

Neostigmine stimulates growth hormone-releasing hormone release into hypophysial portal blood of conscious sheep

E Magnan, M Cataldi, V Guillaume, L Mazzocchi, A Dutour, B Conte-Devolx, P Giraud and C Oliver
Laboratoire de Neuroendocrinologie Experimentale, INSERUM 297, Faculte Medecine Secteur Nord, Marseille, France.

GH secretion is stimulated by the administration of cholinesterase inhibitors (such as pyridostigmine and neostigmine) in several species, including man. On the basis of indirect experiments, it has been postulated that this action is mediated by a decrease in hypothalamic somatostatin release. We have investigated the effect of neostigmine in sheep, since it is possible to collect hypophysial portal blood for GH- releasing hormone (GHRH) and somatostatin determination in this species under a conscious unstressed state. First, after i.v. injection of neostigmine (1 mg), a significant increase in plasma GH levels and an unequivocal potentiation of the GH response to GHRH were observed. Then, we observed that i.v. injection of neostigmine (1 mg) induced an immediate, short-lasting (30 min), and marked increase in GHRH (126.1 +/- 17 vs. 14.5 +/- 2.1 pg/ml; P < 0.01) levels in hypophysial portal blood of rams chronically implanted with perihypophysial cannulae. No change in somatostatin secretion was recorded during the same period. These data suggest that the stimulating effect of cholinergic drugs on GH secretion is mediated by stimulation of GHRH release. A direct effect of neostigmine at the level of pituitary gland is possible and may explain the potentiation of GHRH-induced GH release.

This article has been cited by other articles:

				N. Baccam, G. Alonso, T. Costecalde, P. Fontanaud, F. Molino, I. C. A. F. Robinson, P. Mollard, and P.-F. Mery Dual-Level Afferent Control of Growth Hormone-Releasing Hormone (GHRH) Neurons in GHRH-Green Fluorescent Protein Transgenic Mice J. Neurosci., February 14, 2007; 27(7): 1631 - 1641. [Abstract] [Full Text] [PDF]

				J. E. Drisko, T. D. Faidley, D. Zhang, T. J. McDonald, S. Nicolich, D. F. Hora, P. Cunningham, C. Li, E. Rickes, L. McNamara, et al. Administration of a Nonpeptidyl Growth Hormone Secretagogue, L-163,255, Changes Somatostatin Pattern, But Has No Effect on Patterns of Growth Hormone-Releasing Factor in the Hypophyseal-Portal Circulation of the Conscious Pig Experimental Biology and Medicine, October 2, 1999; 222(1): 70 - 77. [Abstract] [Full Text]

				M. Russell-Aulet, C. A. Jaffe, R. DeMott-Friberg, and A. L. Barkan In Vivo Semiquantification of Hypothalamic Growth Hormone-Releasing Hormone (GHRH) Output in Humans: Evidence for Relative GHRH Deficiency in Aging J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3490 - 3497. [Abstract] [Full Text] [PDF]

				C. A. Jaffe, B. W. Huffman, and R. Demott-Friberg Insulin hypoglycemia and growth hormone secretion in sheep: a paradox revisited Am J Physiol Endocrinol Metab, August 1, 1999; 277(2): E253 - E258. [Abstract] [Full Text] [PDF]

				E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF]

				A. Giustina and J. D. Veldhuis Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human Endocr. Rev., December 1, 1998; 19(6): 717 - 797. [Abstract] [Full Text]

				N. Briard, M. Rico-Gomez, V. Guillaume, N. Sauze, V. Vuaroqueaux, F. Dadoun, Y. Le Bouc, C. Oliver, and A. Dutour Hypothalamic Mediated Action of Free Fatty Acid on Growth Hormone Secretion in Sheep Endocrinology, December 1, 1998; 139(12): 4811 - 4819. [Abstract] [Full Text] [PDF]

				N. Briard, V. Guillaume, C. Frachebois, M. Rico-Gomez, N. Sauze, C. Oliver, and A. Dutour Endotoxin Injection Increases Growth Hormone and Somatostatin Secretion in Sheep Endocrinology, June 1, 1998; 139(6): 2662 - 2669. [Abstract] [Full Text] [PDF]